Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation

Abstract

The EORP-AF Pilot survey provides contemporary data on sex differences in clinical features and management of AF patients participating in the EORP-AF Pilot registry. Female subjects were older and more symptomatic, compared with males, and were more likely to receive rate control. Also, female patients were at higher stroke risk overall, but oral anticoagulation was used in a high proportion of patients.

Management of patients with valvular and non-valvular atrial fibrillation in Poland: Results from Reference Cardiology University Center

“…These findings are contrary to studies mentioned above, in which paroxysmal AF population had less often concomitant conditions. Sex differences in the epidemiology and clinical management of AF are evident and have been described in several studies [6,15,16]. In this analysis, we found that females were older, had more often IHD, severely impaired EF, previous MI and CABG.…”

“…In consequence, AF population remains a heterogenous group due to variety of clinical presentations and treatment options. In most of the reports and registries, AF is associated with at least one concomitant condition, most commonly with hypertension [6,7]. In our population, 97% of AF patients had at least one associated medical condition.…”

“…Recently, several population-based studies and registries have provided information on the incidence, prevalence, and outcome of AF population [6,7,[10][11][12]. However, there are no data regarding the characteristics of AF patients in Poland.…”

“…In 2010 and 2012, the guidelines of the European Society of Cardiology on the management of AF were released as a consequence of well controlled randomized trials such as RELY, ROCKET and ARISTOTLE [1][2][3][4][5]. On the other hand, there is an increasing number of national registries describing prevalence of AF, co-morbidities, stroke risk factors and antithrombotic therapy in real life conditions [6,7]. Data from 7 representative Western European countries illustrating changes in the management of AF have been recently published [8].…”

Clinical Characteristics, Analysisof Autonomic Effects and Prognosis With Patients With Chronic Ischemic Heart Disease With Paroxysmal Atrial Fibrillation

“…При этом динамика параметров комплексного клинического и инструментального обследования определяется тяжестью состояния конкретного больного. Это положение не противоречит данным литературы [1, 7,8]. Можно утверждать, что полученные показатели ассоциируются с возникновения ПФП, а определение предикторов аритмии позволит более эффективно проводить профилактику ССО на ранних стадиях их развития [9,10].…”